Lates News

The biopharmaceutical sector in the Hong Kong stock market remains active, with Fudan Zhangjiang rising by more than 16%, Zhaoyan new medicine rising by more than 6%, and Yasheng Medicine, Pharmaron, and Yiming Innovation all rising by more than 3%.